We are thrilled to announce our plans to establish a cutting-edge isotopes manufacturing site in the USA.
Our goal is to provide GMP-grade Lu-177 n.c.a. to our valued customers by 2024.
The state-of-the-art facility will feature production clean rooms, advanced analytical and microbiology laboratories, precursor isotope recycling systems, and radioactive waste management.
We are committed to delivering high-quality isotopes while prioritizing safety and sustainability.
This milestone marks a significant step forward in our mission to advance nuclear medicine and improve patient care.
Stay tuned for more updates as we embark on this exciting journey!
Read the full article: https://www.prnewswire.com/news-releases/isotopia-molecular-imaging-today-announced-the-appointment-of-todd-hockemeyer-as-chief-executive-officer-of-its-newly-formed-us-subsidiary-isotopia-usa-301855440.html